Several alternative therapeutic strategies have been investigated, including protein kinase C inhibitors [10], darbepoetin alfa [11], endothelin receptor antagonists (ERAs) [12], direct renin inhibitors [13], nuclear factor erythroid 2-related factor 2 activators [14], and combination of ACE inhibitor and ARB [15]
The researchers administered 2.4 mg subcutaneous semaglutide (Wegovy, Novo Nordisk) once weekly to patients with obesity and moderate knee OA, who had at least moderate pain, and compared their outcomes with a placebo group over 68 weeks
-L-,
This cream helps brighten the skin, improve skin tone, and keep the skin nourished and moisturised daily
As an emulsifier, it prevents ingredients from separating and enhances texture by adding volume to a product